Zinc Completed Phase 3 Trials for Wison's Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00212368Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.